153:
170:
Neuhaus, Jacqueline Jacobs, David R. Baker, Jason V. Calmy, Alexandra Duprez, Daniel La Rosa, Alberto Kuller, Lewis H. Pett, Sarah L. Ristola, Matti Ross, Michael J. Shlipak, Michael G. Tracy, Russell Neaton, James D. (2010).
301:
Seddiki, Nabila; Sasson, Sarah C.; SantnerâNanan, Brigitte; Munier, Meeling; Bockel, David van; Ip, Susanna; Marriott, Debbie; Pett, Sarah; Nanan, Ralph; Cooper, David A.; Zaunders, John J. (2009).
545:
303:"Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease"
236:
Babiker, Abdel G Emery, Sean Fätkenheuer, Gerd Gordin, Fred M Grund, Birgit
Lundgren, Jens D Neaton, James D Pett, Sarah L Phillips, Andrew Touloumi, Giota Vjechaj, Michael J (2013).
293:
228:
535:
525:
466:
119:
555:
540:
367:
550:
530:
59:
238:"Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study"
115:
145:
or a placebo through a drip for up to ten days of their stay in hospital. Pett showed that patients treated with
123:
79:
63:
138:
95:
32:
520:
287:
222:
173:"Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection"
133:
Pett led the
Adaptive COVID-19 Treatment Trial (ACTT-EU/UK), a clinical trial into the efficacy of
340:
439:
391:
332:
324:
275:
257:
210:
192:
130:
87:
86:
of infections and the development of optimised treatment pathways for infections. During the
314:
265:
249:
200:
184:
111:
107:
83:
49:
270:
205:
514:
344:
490:
157:
146:
142:
134:
91:
328:
261:
253:
196:
415:
336:
279:
214:
126:. She was promoted to the Chair of the Infectious Diseases theme in 2016.
319:
302:
368:"UCL researchers lead trial to test remdesivir drug on COVID-19 patients"
237:
172:
188:
491:"COVID-19 Tied to Wide Range of Neuropsychiatric Complications"
467:"ACTT-EU/UK trial finds remdesivir speeds up COVID-19 recovery"
149:
recovered 31% faster than those who did not receive treatment.
90:, Pett led a clinical trial that investigated the efficacy of
55:
45:
28:
21:
16:British immunopathologist and COVID-19 researcher
546:Medical Research Council (United Kingdom) people
152:She has also been involved in research on the
8:
292:: CS1 maint: multiple names: authors list (
227:: CS1 maint: multiple names: authors list (
18:
318:
269:
204:
78:is a Professor of Infectious Diseases at
154:neurological complications from COVID-19
358:
536:Academics of University College London
285:
220:
526:Alumni of the University of Edinburgh
7:
461:
459:
177:The Journal of Infectious Diseases
14:
242:Clinical Trials (London, England)
471:MRC Clinical Trials Unit at UCL
444:MRC Clinical Trials Unit at UCL
396:MRC Clinical Trials Unit at UCL
307:European Journal of Immunology
141:. Adult inpatients were given
114:, where she led international
1:
556:21st-century women scientists
60:University of New South Wales
116:randomized controlled trials
82:. Pett is interested in the
541:British medical researchers
572:
118:. In 2013 Pett joined the
551:Women medical researchers
124:University College London
80:University College London
69:
64:University College London
38:
254:10.1177/1740774512440342
122:Clinical Trials Unit at
120:Medical Research Council
106:In 2000 Pett joined the
33:University of Edinburgh
160:that it may induce.
320:10.1002/eji.200838630
164:Selected publications
531:COVID-19 researchers
158:co-morbid conditions
137:as a treatment from
248:(1 Suppl): S5âS36.
139:coronavirus disease
102:Research and career
96:coronavirus disease
94:as a treatment for
366:UCL (2020-04-02).
183:(12): 1788â1795.
131:COVID-19 pandemic
88:COVID-19 pandemic
73:
72:
40:Scientific career
563:
505:
504:
502:
501:
487:
481:
480:
478:
477:
463:
454:
453:
451:
450:
436:
430:
429:
427:
426:
412:
406:
405:
403:
402:
388:
382:
381:
379:
378:
363:
348:
322:
297:
291:
283:
273:
232:
226:
218:
208:
19:
571:
570:
566:
565:
564:
562:
561:
560:
511:
510:
509:
508:
499:
497:
489:
488:
484:
475:
473:
465:
464:
457:
448:
446:
438:
437:
433:
424:
422:
416:"Dr Sarah Pett"
414:
413:
409:
400:
398:
390:
389:
385:
376:
374:
365:
364:
360:
355:
300:
284:
235:
219:
169:
166:
112:New South Wales
108:Kirby Institute
104:
84:immunopathology
62:
50:Immunopathology
29:Alma mater
24:
17:
12:
11:
5:
569:
567:
559:
558:
553:
548:
543:
538:
533:
528:
523:
513:
512:
507:
506:
482:
455:
431:
407:
383:
357:
356:
354:
351:
350:
349:
313:(2): 391â403.
298:
233:
189:10.1086/652749
165:
162:
103:
100:
71:
70:
67:
66:
57:
53:
52:
47:
43:
42:
36:
35:
30:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
568:
557:
554:
552:
549:
547:
544:
542:
539:
537:
534:
532:
529:
527:
524:
522:
521:Living people
519:
518:
516:
496:
492:
486:
483:
472:
468:
462:
460:
456:
445:
441:
435:
432:
421:
417:
411:
408:
397:
393:
387:
384:
373:
369:
362:
359:
352:
346:
342:
338:
334:
330:
326:
321:
316:
312:
308:
304:
299:
295:
289:
281:
277:
272:
267:
263:
259:
255:
251:
247:
243:
239:
234:
230:
224:
216:
212:
207:
202:
198:
194:
190:
186:
182:
178:
174:
168:
167:
163:
161:
159:
155:
150:
148:
144:
140:
136:
132:
127:
125:
121:
117:
113:
109:
101:
99:
97:
93:
89:
85:
81:
77:
76:Sarah L. Pett
68:
65:
61:
58:
54:
51:
48:
44:
41:
37:
34:
31:
27:
20:
498:. Retrieved
494:
485:
474:. Retrieved
470:
447:. Retrieved
443:
440:"Sarah Pett"
434:
423:. Retrieved
419:
410:
399:. Retrieved
395:
392:"Sarah Pett"
386:
375:. Retrieved
371:
361:
310:
306:
288:cite journal
245:
241:
223:cite journal
180:
176:
151:
128:
105:
75:
74:
56:Institutions
39:
129:During the
515:Categories
500:2024-06-17
476:2020-05-15
449:2024-06-17
425:2024-06-17
420:UNSW Sites
401:2020-05-15
377:2024-06-17
353:References
147:remdesivir
143:remdesivir
135:remdesivir
92:remdesivir
23:Sarah Pett
329:1521-4141
262:870252553
197:999829131
495:Medscape
372:UCL News
345:24793084
337:19180462
280:22547421
215:20446848
156:and the
271:3664112
206:2872049
343:
335:
327:
278:
268:
260:
213:
203:
195:
46:Fields
341:S2CID
333:PMID
325:ISSN
294:link
276:PMID
258:OCLC
229:link
211:PMID
193:OCLC
315:doi
266:PMC
250:doi
201:PMC
185:doi
181:201
110:in
98:.
517::
493:.
469:.
458:^
442:.
418:.
394:.
370:.
339:.
331:.
323:.
311:39
309:.
305:.
290:}}
286:{{
274:.
264:.
256:.
246:10
244:.
240:.
225:}}
221:{{
209:.
199:.
191:.
179:.
175:.
503:.
479:.
452:.
428:.
404:.
380:.
347:.
317::
296:)
282:.
252::
231:)
217:.
187::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.